Literature DB >> 15924885

Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells.

Roland Frötschl1, Sandra Weickardt, Solveig Staszewski, Gabriele Kaufmann, Peter Kasper.   

Abstract

Damage to DNA can trigger a variety of stress-related signals that alter the expression of genes associated with numerous biological pathways. In this study, we have used a cDNA microarray representing 1089 genes related to DNA damage and repair, cell cycle, transcription, metabolism and other toxicologically important cell functions to identify genes regulated in response to DNA damage in HepG2 cells induced by UV-activated chlorpromazine (CPZ). CPZ itself is not genotoxic but, upon UV irradiation with a non-genotoxic dose in the UVA range, it produces reactive free radical intermediates with DNA damaging properties. Genotoxicity in HepG2 cells was assessed concomitantly to gene expression profiling using the Comet assay. Kinetic studies were performed at a non-cytotoxic but clearly photogenotoxic concentration of CPZ (1.25 microg/ml) to characterize gene expression profiles at four different time points (3, 7, 15, 23 h) post short-term treatment. The results obtained from repeated experiments display a time-dependent expression pattern of up-regulated and repressed genes with distinct peaks in the number of differentially expressed genes at the 7 and 23 h time points. Most of the genes with altered expression belonged to the functional categories of cell cycle regulation and cell proliferation. A comparison with published expression profiles established in response to other genotoxic compounds showed low levels of concordance, which is most likely caused by the fact that extremely different testing conditions were used.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924885     DOI: 10.1016/j.mrfmmm.2005.03.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis.

Authors:  Joaquim Trigo Marquês; Catarina Frazão De Faria; Marina Reis; Diana Machado; Susana Santos; Maria da Soledade Santos; Miguel Viveiros; Filomena Martins; Rodrigo F M De Almeida
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

2.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

3.  Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs.

Authors:  Bodo Haas; Veronika Klinger; Christina Keksel; Verena Bonigut; Daniela Kiefer; Julia Caspers; Julia Walther; Maria Wos-Maganga; Sandra Weickhardt; Gabriele Röhn; Marco Timmer; Roland Frötschl; Niels Eckstein
Journal:  Cancer Cell Int       Date:  2018-05-04       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.